Progesterone, 99%, reference material

Name: Progesterone, 99%, reference material | 57-83-0
Brand: J&K Chemical
SKU: JK918979_100_MG
Price: 20.1 USD
Availability: InStock

Cat. No JK918979_100_MG

Vendor: J&K Chemical

Product Information

Product Name

Progesterone, 99%, reference material

Brand Name

J&K

Product Number

918979

CAS

57-83-0

Molecular Formula

C21H30O2

Molecular Weight

314.46

Certificate of Analysis (COA)

COA not found

General Information

Synonyms

4-Pregnene-3,20-dione

PubChem CID

5994

IUPAC Name

(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopentaaphenanthren-3-one

InChI Key

RJKFOVLPORLFTN-LEKSSAKUSA-N

SMILES

CC(=O)C@H1CCC@@H2C@@1(CCC@H3C@H2CCC4=CC(=O)CCC@34C)C

Properties

Melting Point

126-132

Safety Information

GHS Symbols

Signal Word

Warning

Hazard Statement

H351

H361

Precautionary Statement

P203

P280

P318

P405

P501

References Data Source From Pubchem

Correction: Overcoming oral medication allergy and cervical stenosis in an anovulatory in vitro fertilization patient: a case report

Publication Name: Journal of Medical Case Reports

Publication Date: 2026-07-13

DOI: 10.1186/s13256-025-05821-y|10.1186/s13256-026-06349-5

Author Correction: Female Infertility and Risk for Later-Life Cardiovascular Disease: Lessons from a Mouse Model of Human Cardiovascular Disease

Publication Name: Reproductive sciences (Thousand Oaks, Calif.)

Publication Date: 2026-05-20

DOI: 10.1007/s43032-025-02026-y|10.1007/s43032-026-02123-6

Title Not Available

Publication Name: MMW Fortschritte der Medizin

Publication Date: 2026-05

DOI: 10.1007/s15006-024-4570-3|10.1007/s15006-025-4588-1|10.1007/s15006-025-4608-1|10.1007/s15006-025-4622-3|10.1007/s15006-025-4624-1|10.1007/s15006-025-4649-5|10.1007/s15006-025-4710-4|10.1007/s15006-025-4742-9|10.1007/s15006-025-4743-8|10.1007/s15006-025-4831-9|10.1007/s15006-025-4880-0|10.1007/s15006-025-4911-x|10.1007/s15006-025-4938-z|10.1007/s15006-025-5102-5|10.1007/s15006-025-5185-z|10.1007/s15006-025-5186-y|10.1007/s15006-025-5211-1|10.1007/s15006-025-5277-9|10.1007/s15006-025-5444-z|10.1007/s15006-025-5502-6|10.1007/s15006-025-5518-y|10.1007/s15006-026-5646-z|10.1007/s15006-026-5670-z|10.1007/s15006-026-5694-4|10.1007/s15006-026-5697-1|10.1007/s15006-026-5839-5|10.1007/s15006-026-5857-3|10.1007/s15006-026-5858-2|10.1007/s15006-026-5880-4|10.1007/s15006-026-5902-2|10.1007/s15006-026-5903-1|10.1007/s15006-026-5904-0|10.1007/s15006-026-5933-8|10.1007/s15006-026-5956-1

Correction: Polycystic Ovary Syndrome (PCOS): A Comprehensive Review of Clinical Approaches, Functional Bioactives, and Nutritional Interventions

Publication Name: Reproductive sciences (Thousand Oaks, Calif.)

Publication Date: 2026-04-17

DOI: 10.1007/s43032-026-02061-3|10.1007/s43032-026-02107-6

Transdiagnostic neuropsychological factors in women with premenstrual dysphoric disorder and premenstrual syndrome: a comparison of the premenstrual and postmenstrual phases

Publication Name: Archives of Women's Mental Health

Publication Date: 2026-03-04

DOI: 10.1007/s00737-026-01684-4

Progesterone, 99%, reference material

Product Information

General Information

Properties

Safety Information

References Data Source From Pubchem

Correction: Overcoming oral medication allergy and cervical stenosis in an anovulatory in vitro fertilization patient: a case report

Author Correction: Female Infertility and Risk for Later-Life Cardiovascular Disease: Lessons from a Mouse Model of Human Cardiovascular Disease

Title Not Available

Correction: Polycystic Ovary Syndrome (PCOS): A Comprehensive Review of Clinical Approaches, Functional Bioactives, and Nutritional Interventions

Transdiagnostic neuropsychological factors in women with premenstrual dysphoric disorder and premenstrual syndrome: a comparison of the premenstrual and postmenstrual phases